CRBU

Caribou Biosciences (CRBU)

About Caribou Biosciences (CRBU)

Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.

Details

Daily high

$1.92

Daily low

$1.84

Price at open

$1.91

52 Week High

$8.33

52 Week Low

$1.50

Market cap

167.2M

Dividend yield

0.00%

Volume

504,381

Avg. volume

819,061

P/E ratio

-1.33

Caribou Biosciences News